ERIC DOBMEIER - 06 Oct 2021 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role: President, CEO, Director
Signature: /s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 06 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 08 Oct 2021, 18:49:50 UTC
Previous filing: 22 Sep 2021
Next filing: 27 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KDNY	Common Stock	Options Exercise		+30,796	+28%		140,633	06 Oct 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KDNY	Restricted Stock Units (RSU)	Options Exercise	$0	-30,796	-33%	$0.000000	61,593	06 Oct 2021	Common Stock	30,796		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F3	The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on October 6, 2021, until fully vested subject to the reporting person's provision of service to the Issuer on each vesting date.